4.7 Article

Lung microbiome alterations in patients with anti-Jo1 antisynthetase syndrome and interstitial lung disease

Related references

Note: Only part of the references are listed.
Article Cell Biology

Enhanced Activity of NLRP3 Inflammasome in the Lung of Patients with Anti-Synthetase Syndrome

Espiridion Ramos-Martinez et al.

Summary: Anti-synthetase syndrome (ASSD) is characterized by inflammatory interstitial lung disease (ILD). This study compared the concentrations of cytokines and molecules associated with inflammasome activation in bronchoalveolar lavage (BAL) of ASSD patients and systemic sclerosis (SSc) patients. Higher levels of caspase-1 and LDH activity were observed in ASSD patients, indicating cell death and inflammasome pathway activation. There were significant differences in IL-18 and IFN-gamma levels between the two groups.

CELLS (2023)

Article Biochemistry & Molecular Biology

The composition of the lung microbiome differs between patients with dermatomyositis and rheumatoid arthritis associated with interstitial lung disease

Yueyan Lou et al.

Summary: Dermatomyositis and rheumatoid arthritis are inflammatory diseases that commonly lead to interstitial lung disease (ILD). Analysis of the lung microbiota composition in patients with these conditions revealed differences in diversity compared to healthy controls, with several unique microbial biomarkers distinguishing between the diseases. Predicted functional and metabolic alterations in the lung microbiota between rheumatoid arthritis, dermatomyositis, and healthy controls may lead to the development of biomarkers for identifying high-risk patients.

FEBS OPEN BIO (2022)

Review Biochemistry & Molecular Biology

The Lung Microbiome during Health and Disease

Kazuma Yagi et al.

Summary: The healthy human lung, traditionally considered sterile, is now known to contain a large number of microbes through culture-independent molecular techniques. Studies have shown significant differences in the lung microbiome between health and respiratory disease. The lung microbiome not only influences disease susceptibility and causes, but is also affected by disease activities and responses to treatment.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Respiratory System

Computed Tomography Findings as Determinants of Local and Systemic Inflammation Biomarkers in Interstitial Lung Diseases: A Retrospective Registry-Based Descriptive Study

David Lang et al.

Summary: This study found that blood lymphocyte and eosinophil fractions, NLR, CRP, and BAL lymphocyte fraction may help differentiate between inflammatory and non-inflammatory/fibrotic patterns in ILD patients.
Article Respiratory System

Relationship of the lung microbiome with PD-L1 expression and immunotherapy response in lung cancer

Hye Jin Jang et al.

Summary: The study found differences in the lung microbiomes of patients with lung cancer based on PD-L1 expression levels and immunotherapy responses. Neisseria and V. dispar were key bacteria that differed significantly in relation to PD-L1 expression levels and immunotherapy responses.

RESPIRATORY RESEARCH (2021)

Review Medicine, General & Internal

Role of Lung Microbiome in Innate Immune Response Associated With Chronic Lung Diseases

Keshav Raj Paudel et al.

FRONTIERS IN MEDICINE (2020)

Article Medical Laboratory Technology

Association between blood microbiome and type 2 diabetes mellitus: A nested case-control study

Jing Qiu et al.

JOURNAL OF CLINICAL LABORATORY ANALYSIS (2019)

Review Rheumatology

Pulmonary involvement in antisynthetase syndrome

Michela Gasparotto et al.

CURRENT OPINION IN RHEUMATOLOGY (2019)

Article Medicine, General & Internal

Influence of Antisynthetase Antibodies Specificities on Antisynthetase Syndrome Clinical Spectrum Time Course

Lorenzo Cavagna et al.

JOURNAL OF CLINICAL MEDICINE (2019)

Article Critical Care Medicine

Lung Microbiota Contribute to Pulmonary Inflammation and Disease Progression in Pulmonary Fibrosis

David N. O'Dwyer et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2019)

Article Respiratory System

The pulmonary microbiome: challenges of a new paradigm

Andre Nathan Costa et al.

JORNAL BRASILEIRO DE PNEUMOLOGIA (2018)

Review Physiology

Paradigms of Lung Microbiota Functions in Health and Disease, Particularly, in Asthma

Elliot Mathieu et al.

FRONTIERS IN PHYSIOLOGY (2018)

Review Immunology

The respiratory tract microbiome and lung inflammation: a two-way street

G. B. Huffnagle et al.

MUCOSAL IMMUNOLOGY (2017)

Article Biotechnology & Applied Microbiology

Veillonella Catalase Protects the Growth of Fusobacterium nucleatum in Microaerophilic and Streptococcus gordonii-Resident Environments

Peng Zhou et al.

APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2017)

Article Respiratory System

Changes in the respiratory microbiome during acute exacerbations of idiopathic pulmonary fibrosis

Philip L. Molyneaux et al.

RESPIRATORY RESEARCH (2017)

Review Physiology

The Microbiome and the Respiratory Tract

Robert P. Dickson et al.

ANNUAL REVIEW OF PHYSIOLOGY, VOL 78 (2016)

Article Biochemical Research Methods

DADA2: High-resolution sample inference from Illumina amplicon data

Benjamin J. Callahan et al.

NATURE METHODS (2016)

Article Cardiac & Cardiovascular Systems

Clinical features and outcomes of interstitial lung disease in anti-Jo-1 positive antisynthetase syndrome

Ana C. Zamora et al.

RESPIRATORY MEDICINE (2016)

Article Microbiology

The lung microbiota in early rheumatoid arthritis and autoimmunity

Jose U. Scher et al.

MICROBIOME (2016)

Article Biotechnology & Applied Microbiology

Characterizing human lung tissue microbiota and its relationship to epidemiological and clinical features

Guoqin Yu et al.

GENOME BIOLOGY (2016)

Article Critical Care Medicine

The Role of Short-Chain Fatty Acids, Produced by Anaerobic Bacteria, in the Cystic Fibrosis Airway

Bojana Mirkovic et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2015)

Article Rheumatology

Patients with non-Jo-1 anti-tRNA-synthetase autoantibodies have worse survival than Jo-1 positive patients

Rohit Aggarwal et al.

ANNALS OF THE RHEUMATIC DISEASES (2014)

Article Critical Care Medicine

Lung microbiome and disease progression in idiopathic pulmonary fibrosis: an analysis of the COMET study

MeiLan K. Han et al.

LANCET RESPIRATORY MEDICINE (2014)

Article Biotechnology & Applied Microbiology

Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2

Michael I. Love et al.

GENOME BIOLOGY (2014)

Article Critical Care Medicine

Lung Microbiota and Bacterial Abundance in Patients with Bronchiectasis when Clinically Stable and during Exacerbation

Michael M. Tunney et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2013)

Article Biochemistry & Molecular Biology

The SILVA ribosomal RNA gene database project: improved data processing and web-based tools

Christian Quast et al.

NUCLEIC ACIDS RESEARCH (2013)

Article Rheumatology

Interstitial Lung Disease in AntiJo-1 Patients With Antisynthetase Syndrome

I. Marie et al.

ARTHRITIS CARE & RESEARCH (2013)

Article Rheumatology

Functional outcome and prognostic factors in anti-Jo1 patients with antisynthetase syndrome

Isabelle Marie et al.

ARTHRITIS RESEARCH & THERAPY (2013)

Article Multidisciplinary Sciences

SCFAs Induce Mouse Neutrophil Chemotaxis through the GPR43 Receptor

Marco A. R. Vinolo et al.

PLOS ONE (2011)

Article Biochemistry & Molecular Biology

Effects of short chain fatty acids on effector mechanisms of neutrophils

Marco A. R. Vinolo et al.

CELL BIOCHEMISTRY AND FUNCTION (2009)

Article Respiratory System

Neutrophil degranulation mediates severe lung damage triggered by streptococcal M1 protein

O. Soehnlein et al.

EUROPEAN RESPIRATORY JOURNAL (2008)